Hydroxychloroquinine has shown positive results when being used to treat patients with Covid-19 (coronavirus). Hydroxychloroquine Sulfate is classified as a DMARD (disease modifying anti-rheumatic drug). It is indicated for rheumatoid arthritis, lupus and malaria attacks. When used for the treatment of rheumatoid arthritis and systemic or chronic discoid lupus erythematosus, it works by reducing the immune system response. This is achieved by decreasing the formation of proteins required to trigger the immune system. Antimalarial properties also make it an effective medicine in the treatment of malaria.
- Loss of hair
- Reduction in appetite
- Pain which occurs in the stomach
In addition to the possible reactions listed above, patients may be affected by other adverse events. Some of these will be serious and will necessitate immediate medical assistance, including strange behavior, seizures, difficulty balancing, bruising appearing on the skin, twitches and other severe side effects that have not been referenced in this paragraph.
Patients being treated for arthritis, lupus or any other conditions should consult their physician if no improvement in symptoms is noticed.